UK Markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
60.67+0.64 (+1.07%)
At close: 4:00PM EST

60.67 0.00 (0.00%)
After hours: 4:31PM EST

Currency in USD

Valuation measures

Market cap (intra-day) 576.05B
Enterprise value 379.6B
Trailing P/E 60.25
Forward P/E 19.19
PEG ratio (5-yr expected) 1182.00
Price/sales (ttm)3.29
Price/book (mrq)4.36
Enterprise value/revenue 33.44
Enterprise value/EBITDA 612.54

Trading information

Stock price history

Beta (5Y monthly) 0.55
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 385.97
52-week low 357.04
50-day moving average 360.47
200-day moving average 368.22

Share statistics

Avg vol (3-month) 39.42M
Avg vol (10-day) 37.87M
Shares outstanding 51.25B
Float 1.25B
% held by insiders 10.40%
% held by institutions 180.17%
Shares short (12 Nov 2020) 421.71M
Short ratio (12 Nov 2020) 42.06
Short % of float (12 Nov 2020) 41.73%
Short % of shares outstanding (12 Nov 2020) 41.73%
Shares short (prior month 14 Oct 2020) 420.5M

Dividends & splits

Forward annual dividend rate 42.72
Forward annual dividend yield 44.53%
Trailing annual dividend rate 32.67
Trailing annual dividend yield 34.45%
5-year average dividend yield 42.94
Payout ratio 4272.45%
Dividend date 329 Dec 2020
Ex-dividend date 413 Dec 2020
Last split factor 22:1
Last split date 327 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Sep 2020

Profitability

Profit margin 5.48%
Operating margin (ttm)21.36%

Management effectiveness

Return on assets (ttm)5.15%
Return on equity (ttm)6.46%

Income statement

Revenue (ttm)23.15B
Revenue per share (ttm)18.38
Quarterly revenue growth (yoy)17.40%
Gross profit (ttm)17.77B
EBITDA 6.35B
Net income avi to common (ttm)1.27B
Diluted EPS (ttm)1.01
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.96B
Total cash per share (mrq)19.91
Total debt (mrq)29.29B
Total debt/equity (mrq)167.65
Current ratio (mrq)3.25
Book value per share (mrq)13.92

Cash flow statement

Operating cash flow (ttm)8.83B
Levered free cash flow (ttm)4.14B